.jpg?#)
Zydus Lifesciences Q1 Review: Systematix Maintains 'Hold', Revises Target Price - Here's Why
Systematix revised target price stands at Rs 1,020, based on 25x FY27 EPS, and retain a Hold on the stock.
Systematix revised target price stands at Rs 1,020, based on 25x FY27 EPS, and retain a Hold on the stock.
What's Your Reaction?
